Top Banner
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 204623Orig1s000 CHEMISTRY REVIEW(S)
16

CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA

Mar 19, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA

CENTER FOR DRUG EVALUATION AND

RESEARCH

APPLICATION NUMBER:

204623Orig1s000

CHEMISTRY REVIEW(S)

Page 2: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 3: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 4: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 5: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 6: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA

---------------------------------------------------------------------------------------------------------This is a representation of an electronic record that was signedelectronically and this page is the manifestation of the electronicsignature.---------------------------------------------------------------------------------------------------------/s/----------------------------------------------------

YONG HU02/08/2013

PRASAD PERI02/08/2013I concur

Reference ID: 3258383

Page 7: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 8: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 9: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 10: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 11: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 12: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 13: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 14: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 15: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 16: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA

---------------------------------------------------------------------------------------------------------This is a representation of an electronic record that was signedelectronically and this page is the manifestation of the electronicsignature.---------------------------------------------------------------------------------------------------------/s/----------------------------------------------------

YONG HU02/01/2013Corrected version.

PRASAD PERI02/01/2013I concur

Reference ID: 3254049